InoRx published a bioequivalence study in an anemic population where the previous CRO couldn't open eight planned sites on time.

InoRx is a next-generation Contract Research Organization (CRO) built to accelerate clinical development through innovation, patient access, and operational excellence. Headquartered in the U.S. with operations in India, InoRx leverages its affiliate network of academic medical centers and clinics, high quality standards, and experienced clinical operations, to deliver faster, more cost effective, highly reliable clinical studies for sponsors worldwide. Backed by SRM Group InoRx is part of the SRM Group, a diversified global enterprise with $1.4 billion in revenue and thousands of employees across healthcare, education, technology, and more. SRM’s decades of experience and reputation in medical research, hospital systems, and academic excellence provide InoRx with scientific expertise, infrastructure, and access to a vast network of clinicians, research sites, and patients.